These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21938226)

  • 41. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.
    Kelley DL; Mangini J; Lopez-Plaza I; Triulzi DJ
    Transfusion; 2000 Apr; 40(4):439-42. PubMed ID: 10773056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An audit of platelet transfusion indications in acute leukaemia patients: six-year experience at an Academic Centre.
    Jaime-Pérez JC; García-Salas G; Turrubiates-Hernández GA; Alvarado-Navarro DM; Marfil-Rivera LJ; Gómez-Almaguer D
    Blood Transfus; 2021 Jan; 19(1):37-44. PubMed ID: 33196413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. National comparative audit of the use of platelet transfusions in the UK.
    Qureshi H; Lowe D; Dobson P; Grant-Casey J; Parris E; Dalton D; Hickling K; Waller F; Howell C; Murphy MF;
    Transfus Clin Biol; 2007 Dec; 14(6):509-13. PubMed ID: 18359658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Estcourt LJ; Stanworth S; Doree C; Trivella M; Hopewell S; Blanco P; Murphy MF
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010984. PubMed ID: 26505729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of cross-match compatible platelets in multi transfused haemato-oncology patients refractory to platelet transfusion.
    Chavan A; Sharma RR; Saikia B; Malhotra P; Prakash S; Hans R; Marwaha N
    Transfus Apher Sci; 2019 Dec; 58(6):102657. PubMed ID: 31706911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications.
    Gupta P; LeRoy SC; Luikart SD; Bateman A; Morrison VA
    Leuk Res; 1999 Oct; 23(10):953-9. PubMed ID: 10573142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogen-reduced platelets for the prevention of bleeding.
    Estcourt LJ; Malouf R; Hopewell S; Trivella M; Doree C; Stanworth SJ; Murphy MF
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009072. PubMed ID: 28756627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet function testing during 5-day storage of single and random donor plateletpheresis.
    Akay OM; Gündüz E; Başyiğit H; Gulbas Z
    Transfus Apher Sci; 2007 Jun; 36(3):285-9. PubMed ID: 17602871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of Pooled Platelet Transfusion in Concordant and Discordant Groups among Dengue Patients.
    Bhat A; Chowdappa V; Masamatti SS
    J Clin Diagn Res; 2016 Jul; 10(7):EC21-4. PubMed ID: 27630853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic efficacy of different types of platelet concentrates in thrombocytopenic patients.
    Singh RP; Marwaha N; Malhotra P; Dash S
    Indian J Hematol Blood Transfus; 2008 Mar; 24(1):16-22. PubMed ID: 23100935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ABO and platelet transfusion revisited.
    Heal JM; Rowe JM; Blumberg N
    Ann Hematol; 1993 Jun; 66(6):309-14. PubMed ID: 8318561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of bacterial inactivation in random donor platelets and single-donor apheresis platelets by the INTERCEPT blood system.
    Makroo RN; Sardana R; Mediratta L; Butta H; Thakur UK; Agrawal S; Chowdhry M; Kumar S; Chokroborty S
    Asian J Transfus Sci; 2018; 12(2):146-153. PubMed ID: 30692800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.
    Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC; ;
    Pediatr Crit Care Med; 2019 Feb; 20(2):e61-e69. PubMed ID: 30422914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Let Us Know Transfusion Triggers for Prophylactic Use of Platelet Concentrate-Analysis of Compliance with Recent Transfusion Guidelines in a Large Academic Medical Center.
    Czempik PF; Herzyk J; Wilczek D
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
    Mair B; Benson K
    Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Giant Platelets in Platelet Donors - A Blessing in Disguise?
    Roy AD; Choudhury N; Ray D
    J Clin Diagn Res; 2015 Jun; 9(6):EC01-3. PubMed ID: 26266124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Associations between ABO non-identical platelet transfusions and patient outcomes-A multicenter retrospective analysis.
    Bougie DW; Reese SE; Birch RJ; Bookwalter DB; Mitchell PK; Roh D; Kreuziger LB; Cable RG; Goel R; Gottschall J; Hauser RG; Hendrickson JE; Hod EA; Josephson CD; Kahn S; Kleinman SH; Mast AE; Ness PM; Roubinian NH; Sloan S;
    Transfusion; 2023 May; 63(5):960-972. PubMed ID: 36994786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of transfusion reactions associated with prestorage-pooled platelet components.
    Tormey CA; Sweeney JD; Champion MH; Pisciotto PT; Snyder EL; Wu Y
    Transfusion; 2009 Jun; 49(6):1242-7. PubMed ID: 19389029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.